|
At
what price?
With a policy over a decade old, the Indian pharma price control
model must change. What options will be presented before the
cabinet this April? Is there a consensus on a particular price
monitoring model? Deepali Gupta analyses
'We
guide entrepreneurs to hit capital markets'
IPOs are the magic word for small companies trying to make
it big. For pharma companies that are thinking big, floating
an IPO is the obvious choice. Even with all the good omens
and the bull run up, IPOs are to be dealt with caution. Sanjay
Jain, the Vice-President of SBI Capital Markets shares his
thoughts on the IPO process with Nandini Patwardhan
Ranbaxy
on the growth path
Ranbaxy Laboratories recently announced the acquisition of
a generics company, Ethimed NV, in Belgium.
Shasun
acquires custom synthesis business
Shasun Chemicals and Drugs announced that it completed its
acquisition of the pharmaceutical custom synthesis business
of Rhodia Group.
Zydus
Cadila files IND application for NME - ZYH2
Zydus Cadila has filed another IND (Investigational New Drug)
application for the New Molecular Entity (NME)— ZYH2
with the Drug Controller General of India (DCGI).
Biocon
acquires Nobex's assets
Biocon announced that it had put up the winning bid for acquiring
all the assets of Nobex Corporation, a drug development company
specialising in a proprietary drug delivery system to enable
oral delivery of peptide drugs.
Size
does matter
Everyone in the business world chants the 'think big' mantra.
But a bunch of scientists talked small at the two-day workshop
at the World Nano-Economic Congress (WNEC) India, in Mumbai
on March 28th-29th at Hyatt Regency.
Strategies
for better drug discovery
All about drug discovery under one roof is the best line to
describe the -three-day event on Asia Drug Discovery and Development.
Organised by Marcus Evans at Hotel Taj Lands End in Mumbai,
from 20 to 22 March, it was the meeting point of dignitaries
from the various fields of research, finance and technology.
Johnson
& Johnson launches VITROS 5, 1 FS chemistry system
Ortho-Clinical Diagnostic, a division of Johnson & Johnson
made an official announcement of the launch of its new VITROS
chemistry system in India on April 4th in Mumbai. VITROS 5,
1 FS chemistry system is the intellicheck technology, which
offers integrity checks at every level of testing.
Pharmaceutical
Manufacturing Summit 2006
“ManuPharma”, Pharmaceutical Manufacturing Summit
2006, was organised by “Marcus Evans Event” at Le-Montreux
Palace hotel at Switzerland from March 27 to 29, 2006. This
event was designed for senior executives from the pharmaceutical
manufacturing industry.
|
